Harding Loevner International Small Companies Portfolio  (HLMSX)

Fund Overview

Fund Overview

Share Class

Investor

NAV | as of 10/18/2019

$15.18
-$0.05 (-0.33%)

Morningstar | Style Box

V B G L M S

Overall Morningstar Rating



Rated against 122 Foreign Small/Mid Growth funds as of 09/30/2019

View Morningstar Details

Growth of $10,000 (Hypothetical)

Since Inception 03/26/2007 to 09/30/2019 = $18,854.54

  • 3YR
  • 5YR
  • 10YR
  • INCEP.
INCEP.
  • 3YR
  • 5YR
  • 10YR
  • INCEP.

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879 or visit our website at amgfunds.com. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown. Performance Data shown does not reflect the 2.00% redemption fee imposed on the shares held 90 days or less; otherwise, total returns would be reduced.

Objective

The Portfolio seeks long-term capital appreciation through investments in equity securities of small companies based outside the United States.

Why Consider

  • The Fund may be appropriate for your overall investment allocation if you are looking to gain exposure to non-US small cap investments
  • Harding Loevner monitors and manages risk at the security, portfolio and enterprise levels
  • The Firm's extensive experience and structured research process has led to consistent execution of its high quality, growth investment philosophy

Documents

View All Documents
Jafar Rizvi, CFA

Jafar Rizvi, CFA

Co-Lead Portfolio Manager

See Our Approach Read Bio
Anix Vyas, CFA

Anix Vyas, CFA

Co-Lead Portfolio Manager

See Our Approach Read Bio

Performance

Performance

Read Important Investment Disclosures

Returns

 

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879 or visit our website at amgfunds.com. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown. Performance Data shown does not reflect the 2.00% redemption fee imposed on the shares held 90 days or less; otherwise, total returns would be reduced.

Expense Ratios

  • Gross Expense Ratio: 1.75%
  • Net Expense Ratio: 1.40%
  • Expense Cap Expiration Date: 02/28/2020

Distributions & Pricing


    • Ex-Date Total Distribution Income Short-term Cap Gains Long-term Cap Gains
      Dec 18, 2018 $0.985519 $0.100589 $0.884930
      Dec 15, 2017 $0.191511 $0.045975 $0.075916 $0.069620
      Dec 18, 2015 $0.205618 $0.071007 $0.134611
      Dec 19, 2014 $0.284114 $0.028663 $0.047329 $0.208122
      Dec 20, 2013 $0.921223 $0.052555 $0.266590 $0.602078
      Dec 20, 2012 $0.113092 $0.113092
      Dec 19, 2011 $0.065636 $0.065636
      Dec 16, 2010 $0.032057 $0.032057
      Dec 17, 2009 $0.047900 $0.047900
      Dec 17, 2008 $0.072300 $0.072300
      Dec 13, 2007 $0.100200 $0.056800 $0.043400

Risk & Return Stats

As of: 09/30/2019

View All Characteristics & Stats

Portfolio & Holdings

Portfolio & Holdings

Top Holdings (Equity)

As of: 09/30/2019

Ariake 2.62%
Carl Zeiss Meditec 2.48%
Alten 2.33%
RUBIS 2.08%
Core Laboratories 1.92%
Bechtle 1.91%
Abcam 1.85%
Reply 1.79%
Vaisala 1.72%
SMS 1.70%
% in Top 10 Holdings 20.40%
View Holding Details Read Important Investment Disclosures

Regional Allocation

As of: 09/30/2019

Investment Approach

Investment Approach

Harding Loevner International Small Companies Portfolio

The International Small Companies Portfolio invests in high-quality, growing companies with modest market capitalization outside of the United States. Its investment universe includes developed and emerging markets.

Following a disciplined investment process focused on collaborative yet accountable decision-making, analysts study global industries to understand their competitive structures, assess the long-term risks and fair values of their constituent companies, and recommend those with high fundamental business quality and durable growth prospects. The Fund's diversified portfolio is built from the bottom-up, and seeks to realize superior risk-adjusted returns. Mr. Jafar Rizvi, CFA and Mr. Anix Vyas, CFA are the Co-Lead Portfolio Managers.


The Case for International Small-Cap

 
International small-cap stocks are often under-utilized in a portfolio. An allocation may offer investors the potential to generate higher absolute and risk-adjusted returns.
Read Full Perspective

Harding Loevner: Disciplined Quality Growth Investors

 
Simon Hallett, CFA, Co-Chief Investment Officer, discusses Harding Loevner’s investment philosophy, team culture and structured approach to growth investing.
Watch Video More About Harding Loevner

About

About Harding Loevner

Background

Harding Loevner manages global and non-U.S. equity portfolios following a consistent philosophy focused on long-term investment in growing companies with high-quality fundamentals. The Firm believes diversified portfolios of the stocks of companies meeting its quality-growth criteria, purchased at reasonable prices, offer superior risk-adjusted returns over the long term.

Learn More

More Funds From Harding Loevner

HLEMX

Harding Loevner Emerging Markets Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based in emerging markets.

View Fund Details

HLMOX

Harding Loevner Frontier Emerging Markets Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based in frontier and smaller emerging markets.

View Fund Details

HLMGX

Harding Loevner Global Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based both inside and outside the United States.

View Fund Details

HLMEX

Harding Loevner Institutional Emerging Markets Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based in emerging markets.

View Fund Details

HLMNX

Harding Loevner International Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.

View Fund Details

HLIRX

Harding Loevner International Equity Research Portfolio

The Fund seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.

View Fund Details

Founded

1989


Headquarters

Bridgewater, NJ


Affiliate Since

2009


AUM

$68.8B

Funds to Consider

ARDEX

River Road Dividend All Cap Value Fund

Seeks to provide high current income and, secondarily, long-term capital appreciation by investing primarily in a diversified, all cap portfolio of income producing equity securities.


Overall Morningstar Rating

Rated against 1090 Large Value funds as of 09/30/2019
★★★

ARDEX
Russell 3000® Value Index

Quarterly performance (%) data as of 09/30/2019

Fund Detail Read Important Investment Disclosures

YAFFX

Yacktman Focused Fund

The Fund seeks long-term capital appreciation and, to a lesser extent, current income by primarily investing in common stocks of U.S. companies.


Overall Morningstar Rating

Rated against 1090 Large Value funds as of 09/30/2019
★★★★

YAFFX
S&P 500 Index
Russell 1000® Value Index

Quarterly performance (%) data as of 09/30/2019

Fund Detail Read Important Investment Disclosures

MGFIX

Loomis Sayles Bond Fund

Seeks a high level of current income by investing in a flexible portfolio of fixed income securities.


Overall Morningstar Rating

Rated against 539 Intermediate Core-Plus Bond funds as of 09/30/2019
★★★★

MGFIX
Bloomberg Barclays U.S. Government/Credit Bond Index

Quarterly performance (%) data as of 09/30/2019

Fund Detail Read Important Investment Disclosures

Discover how AMG Funds brings more than 100 products from over 30 independent boutiques together under one flag.

Learn More About AMG Funds
  Back To Top